SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.560-2.5%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (3321)8/27/1999 1:57:00 AM
From: BDR  Read Replies (1) of 10293
 
Did Bill make a call on this one? Directors run like hell.

Sabratek Announces Resignations of
Two Directors

August 26, 1999

SKOKIE, Ill., Aug. 25 /PRNewswire/
via NewsEdge Corporation -- The
Board of Directors of Sabratek
Corporation (Nasdaq: SBTKE) today
announced that L. Peter Smith,
Chairman and Chief Executive Officer
of Ralin Medical, Inc., and Mark
Lampert, Managing Partner,
Biotechnology Value Fund, L.P., have
resigned from the Sabratek Board,
effective immediately. Mr. Smith
joined the Board in October 1992,
and Mr. Lampert joined in May
1996.

The Board said that both Mr. Smith
and Mr. Lampert cited the need to
devote their full business attention
to other endeavors as the reason
for their decisions to leave. The
Board also said that although it was
sorry to see these Directors leave, it
will keep its number of Board
members at seven instead of nine in
order to streamline its
decision-making process and to
accelerate efforts to enhance
shareholder value. The Board
gratefully acknowledges the
contribution that these two
gentlemen made to the Company.

Based in Skokie, Illinois, Sabratek
Corporation is a clinical connectivity
company. The Company develops,
produces and markets
technologically advanced,
easy-to-use, smart, interactive,
Web-enabled medical systems that
work seamlessly together to allow
health-care providers to lower costs,
expand access and maintain quality
across the continuum of care.

This press release contains
forward-looking statements. The
actual results might differ materially
from those projected in the
forward-looking statements.
Additional information concerning
factors that could cause actual
results to materially differ from
those in the forward-looking
statements are contained in the
Company's periodic reports filed
under the Securities Exchange Act of
1934, as amended (copies of which
are available upon request from the
Company's Investor Relations
Department).

SOURCE Sabratek Corporation

/CONTACT: John Reilly, Chief
Financial Officer of Sabratek
Corporation, 847-720-2400; or
Investor Relations - Mark Kollar or
Jeffrey Rendin of Broadgate
Consultants, Inc., 212-232-2222/
(SBTKE)

[Copyright 1999, PR Newswire]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext